Epigenetic inactivation of Betaig-h3 gene in human cancer cells

Genze Shao1, Jessica Berenguer, Alain C Borczuk

  • 1Center for Radiological Research and Department of Pathology, Columbia University, New York, New York 10032, USA.

Cancer Research
|May 3, 2006
PubMed

Insights

CpG island methylation silences the Betaig-h3 gene in human cancers. Demethylation reactivates Betaig-h3 expression, suggesting promoter methylation is critical for tumor suppressor gene inactivation.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Gene silencing via promoter CpG island methylation is a key mechanism for tumor suppressor gene inactivation in human cancers.
  • The Betaig-h3 gene, encoding an extracellular matrix protein, is frequently downregulated or silenced in various cancer cell lines.
  • Understanding the molecular mechanisms behind Betaig-h3 silencing is crucial for cancer research.

Purpose of the Study:

  • To investigate the role of DNA methylation in the promoter region of the Betaig-h3 gene in human cancers.
  • To determine the correlation between Betaig-h3 promoter methylation and gene expression levels.
  • To explore the potential of demethylation agents in restoring Betaig-h3 expression.

Main Methods:

  • Analysis of DNA methylation patterns in the Betaig-h3 CpG island across normal, immortalized, and cancer cell lines (lung, prostate, mammary, kidney).
  • Treatment of silenced tumor cell lines with 5-aza-2'-deoxycytidine to induce demethylation and assess gene reactivation.
  • Luciferase reporter assays to evaluate the functional impact of Betaig-h3 promoter methylation and demethylation on gene activity.
  • Examination of Betaig-h3 promoter methylation and protein levels in primary lung tumors.

Main Results:

  • A strong correlation was observed between hypermethylation of the Betaig-h3 promoter and the loss of gene expression.
  • Demethylation using 5-aza-2'-deoxycytidine successfully reactivated Betaig-h3 expression in silenced cancer cell lines.
  • Luciferase assays confirmed that unmethylated Betaig-h3 promoter restored activity, while in vitro methylation inactivated it.
  • CpG methylation of the Betaig-h3 promoter was detected in primary lung tumors with reduced Betaig-h3 protein levels.

Conclusions:

  • Promoter methylation plays a critical role in the silencing of the Betaig-h3 gene in human tumor cells.
  • Betaig-h3 gene silencing through promoter hypermethylation is a significant mechanism in cancer development.
  • Targeting epigenetic modifications like DNA methylation could offer therapeutic strategies for cancers involving Betaig-h3 silencing.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Histone Variants at the Centromere02:30

Histone Variants at the Centromere

Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3 variants are also...
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...